Evidence map›Paper›PMID 32929655›Full record

ArticleMolecular biology reports2020

Inositol hexakisphosphate kinase 2 promotes cell death of anterior horn cells in the spinal cord of patients with amyotrophic lateral sclerosis.

Eiichiro Nagata, Natsuko Fujii, Saori Kohara, Chisa Okada, Tadayuki Satoh, Susumu Takekoshi, Masaki Takao, Ban Mihara, Shunya Takizawa

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Eiichiro NagataDepartment of Neurology, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan. enagata@is.icc.u-tokai.ac.jp.ORCID http://orcid.org/0000-0001-6902-8309
Natsuko FujiiDepartment of Neurology, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan.
Saori KoharaDepartment of Neurology, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan.
Chisa OkadaSupport Center for Medical Research and Education, Tokai University, Isehara, Japan.
Tadayuki SatohSupport Center for Medical Research and Education, Tokai University, Isehara, Japan.
Susumu TakekoshiDepartment of Clinical Pathology, Tokai University School of Medicine, Isehara, Japan.
Masaki TakaoDepartment of Clinical Laboratory, National Center of Neurology and Psychiatry (NCNP), National Center Hospital, Tokyo, Japan.
Ban MiharaDepartment of Neurology, Mihara Memorial Hospital, Gunma, Japan.
Shunya TakizawaDepartment of Neurology, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan.
Tokai University · JPInstitute of Brain and Blood Vessels · JPNational Center of Neurology and Psychiatry · JP

Funding

Japan Society for the Promotion of Science 16H06277Japan Society for the Promotion of Science JP 19K07851
6 · The paper itself

Abstract

We have previously reported that inositol hexakisphosphate kinase (InsP

Indexed as

AgedAged, 80 and overAmyotrophic Lateral SclerosisAnterior Horn CellsAutopsyCasein Kinase IICell DeathCell NucleusCytoplasmFemaleGene Expression RegulationHSP90 Heat-Shock ProteinsHumansImmunohistochemistryMaleMiddle AgedCasein Kinase IIHSP90 Heat-Shock ProteinsIP6K1 protein, humanPhosphotransferases (Phosphate Group Acceptor)Proto-Oncogene Proteins c-aktAkt depletionAmyotrophic lateral sclerosisCell deathInositol hexakisphosphate kinase 2Spinal cord anterior horn cells

Identifiers

PMID32929655
OpenAlexW3085364143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.